...
首页> 外文期刊>Cardiovascular Ultrasound >Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease
【24h】

Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease

机译:运动,多巴酚丁胺-阿托品和双嘧达莫-阿托品应力超声心动图在检测冠心病中的比较

获取原文

摘要

Background Dipyridamole and dobutamine stress echocardiography testing are most widely utilized, but their sensitivity remained suboptimal in comparison to routine exercise stress echocardiography. The aim of our study is to compare, head-to-head, exercise, dobutamine and dipyridamole stress echocardiography tests, performed with state-of-the-art protocols in a large scale prospective group of patients. Methods Dipyridamole-atropine (Dipatro: 0.84 mg/kg over 10 min i.v. dipyridamole with addition of up to 1 mg of atropine), dobutamine-atropine (Dobatro: up to 40 mcg/kg/min i.v. dobutamine with addition of up to 1 mg of atropine) and exercise (Ex, Bruce) were performed in 166 pts. Of them, 117 pts without resting wall motion abnormalities were enrolled in study (91 male; mean age 54 ± 10 years; previous non-transmural myocardial infarction in 32 pts, angina pectoris in 69 pts and atypical chest pain in 16 pts). Tests were performed in random sequence, in 3 different days, within 5 day period under identical therapy. All patients underwent coronary angiography. Results Significant coronary artery disease (CAD; ≥50% diameter stenosis) was present in 69 pts (57 pts 1-vessel CAD, 12 multivessel CAD) and absent in 48 pts. Sensitivity (Sn) was 96%, 93% and 90%, whereas specificity (Sp) was 92%, 92% and 87% for Dobatro, Dipatro and Ex, respectively (p = ns). Concomitant beta blocker therapy did not influence peak rate-pressure product and Sn of Dobatro and Dipatro (p = ns). Conclusion When state-of-the-art protocols are used, dipyridamole and dobutamine stress echocardiography have comparable and high diagnostic accuracy, similar to maximal post-exercise treadmill stress echocardiography.
机译:背景双嘧达莫和多巴酚丁胺负荷超声心动图测试得到最广泛的应用,但与常规运动负荷超声心动图相比,其敏感性仍然欠佳。我们的研究目的是比较,比较先进的方案在大量潜在患者中进行的头部,头部,运动,多巴酚丁胺和潘生丁应力超声心动图检查。方法双嘧达莫-阿托品(Dipatro:0.84 mg / kg,在10分钟内静脉注射双嘧达莫,添加至多1 mg阿托品),多巴酚丁胺-阿托品(Dobatro:至多40 mcg / kg / min,静脉内多巴酚丁胺,添加至多1 mg进行了166分的运动(例如阿托品)和运动(例如,布鲁斯)。其中纳入117例无静息壁运动异常的患者(91例男性;平均年龄54±10岁;先前的非透壁性心肌梗死32例,心绞痛69例,非典型性胸痛16例)。在相同的疗法下,于5天之内在3个不同的天中以随机顺序进行测试。所有患者均接受冠状动脉造影。结果69例患者中存在严重的冠状动脉疾病(CAD;直径狭窄≥50%)(1血管CAD者57例,多支血管CAD者12例),无48例。 Dobatro,Dipatro和Ex的灵敏度(Sn)分别为96%,93%和90%,而特异性(Sp)分别为92%,92%和87%(p = ns)。伴随的β受体阻滞剂治疗不会影响Dobatro和Dipa​​tro的峰值速率压力乘积和Sn(p = ns)。结论使用最先进的方案时,潘生丁和多巴酚丁胺应力超声心动图具有可比性和较高的诊断准确性,类似于最大运动后跑步机应力超声心动图。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号